Goncharova N D, Chigarova O A, Oganyan T E
Laboratory of Experimental Endocrinology, Research Institute of Medical Primatology, Sochi, Russia.
Bull Exp Biol Med. 2018 Nov;166(1):86-91. doi: 10.1007/s10517-018-4294-4. Epub 2018 Nov 18.
The effect of selective antagonist of the arginine vasopressin (AVP) V1b receptors on the secretion of ACTH and corticosteroids in response to insulin-induced hypoglycemia and injection of AVP is studied in old Macaca mulatta females with depression-like and anxious behavior. Intravenous antagonist in a dose of 1.1-1.7 μg/kg inhibits the increase of ACTH concentration, induced by hypoglycemia or injection of AVP. The degree of increase in the concentrations of hydrocortisone and dehydroepiandrosterone sulfate has not changed or increased. The effects of AVP antagonist prove that previously detected disorders in the reaction of the hypothalamic-pituitary-adrenal system in old Macaca mulatta with depression-like and anxious behavior could be caused by excessive activation of vasopressin V1b receptors on the pituitary corticotrophs, while the use of V1b receptor antagonists seems to be a promising method for prevention of these disorders.
在患有类似抑郁和焦虑行为的老年雌性恒河猴中,研究了精氨酸加压素(AVP)V1b受体选择性拮抗剂对胰岛素诱导的低血糖和注射AVP后促肾上腺皮质激素(ACTH)和皮质类固醇分泌的影响。剂量为1.1 - 1.7μg/kg的静脉拮抗剂可抑制低血糖或注射AVP诱导的ACTH浓度升高。氢化可的松和硫酸脱氢表雄酮浓度的升高程度未改变或有所增加。AVP拮抗剂的作用证明,先前在患有类似抑郁和焦虑行为的老年恒河猴中检测到的下丘脑 - 垂体 - 肾上腺系统反应紊乱,可能是由于垂体促肾上腺皮质细胞上的加压素V1b受体过度激活所致,而使用V1b受体拮抗剂似乎是预防这些紊乱的一种有前景的方法。